BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Camilleri M. Peripheral mechanisms in irritable bowel syndrome. N Engl J Med. 2012;367:1626-1635. [PMID: 23094724 DOI: 10.1056/nejmra1207068] [Cited by in Crossref: 202] [Cited by in F6Publishing: 101] [Article Influence: 20.2] [Reference Citation Analysis]
Number Citing Articles
1 Camilleri M, Oduyebo I, Halawi H. Chemical and molecular factors in irritable bowel syndrome: current knowledge, challenges, and unanswered questions. Am J Physiol Gastrointest Liver Physiol 2016;311:G777-84. [PMID: 27609770 DOI: 10.1152/ajpgi.00242.2016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
2 de la Cuesta-Zuluaga J, Mueller NT, Corrales-Agudelo V, Velásquez-Mejía EP, Carmona JA, Abad JM, Escobar JS. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut. Diabetes Care. 2017;40:54-62. [PMID: 27999002 DOI: 10.1155/2016/7030795] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
3 Petschow BW, Burnett B, Shaw AL, Weaver EM, Klein GL. Serum-derived bovine immunoglobulin/protein isolate: postulated mechanism of action for management of enteropathy. Clin Exp Gastroenterol 2014;7:181-90. [PMID: 24904221 DOI: 10.2147/CEG.S62823] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
4 Opekun AR, Balesh AM, Shelby HT. Use of the Biphasic (13)C-Sucrose/Glucose Breath Test to Assess Sucrose Maldigestion in Adults with Functional Bowel Disorders. Biomed Res Int. 2016;2016:7952891. [PMID: 27579322 DOI: 10.1155/2016/7952891] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
5 Camilleri M, Shin A, Busciglio I, Carlson P, Acosta A, Bharucha AE, Burton D, Lamsam J, Lueke A, Donato LJ, Zinsmeister AR. Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion. Am J Physiol Gastrointest Liver Physiol 2014;307:G508-16. [PMID: 25012842 DOI: 10.1152/ajpgi.00178.2014] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
6 Grover M, Camilleri M. Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases. J Gastroenterol. 2013;48:177-181. [PMID: 23254779 DOI: 10.1007/s00535-012-0726-5] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
7 Halawi H, Camilleri M. Pharmacogenetics and the treatment of functional gastrointestinal disorders. Pharmacogenomics 2017;18:1085-94. [PMID: 28686075 DOI: 10.2217/pgs-2017-0049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
8 Iturrino J, Camilleri M, Busciglio I, Burton D, Zinsmeister AR. Pilot trial: pregabalin on colonic sensorimotor functions in irritable bowel syndrome. Dig Liver Dis 2014;46:113-8. [PMID: 24095618 DOI: 10.1016/j.dld.2013.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
9 Li YJ, Dai C, Jiang M. Mechanisms of Probiotic VSL#3 in a Rat Model of Visceral Hypersensitivity Involves the Mast Cell-PAR2-TRPV1 Pathway. Dig Dis Sci. 2019;64:1182-1192. [PMID: 30560330 DOI: 10.1007/s10620-018-5416-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
10 Linlawan S, Patcharatrakul T, Somlaw N, Gonlachanvit S. Effect of Rice, Wheat, and Mung Bean Ingestion on Intestinal Gas Production and Postprandial Gastrointestinal Symptoms in Non-Constipation Irritable Bowel Syndrome Patients. Nutrients. 2019;11:2061. [PMID: 31484315 DOI: 10.3390/nu11092061] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
11 Lee HJ, Choi JK, Ryu HS, Choi CH, Kang EH, Park KS, Min YW, Hong KS. Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders. J Neurogastroenterol Motil 2017;23:9-19. [PMID: 28049862 DOI: 10.5056/jnm16124] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
12 Waldman SA, Camilleri M. Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders. Gut 2018;67:1543-52. [PMID: 29563144 DOI: 10.1136/gutjnl-2018-316029] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 9.5] [Reference Citation Analysis]
13 Guan T, Li T, Cai W, Huang D, Ouyang P, Wang Y, Chen H, Wu K, Ma X. HTR3A and HTR3E gene polymorphisms and diarrhea predominant irritable bowel syndrome risk: evidence from a meta-analysis. Oncotarget. 2017;8:100459-100468. [PMID: 29245992 DOI: 10.18632/oncotarget.19682] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
14 El-Salhy M. Possible role of intestinal stem cells in the pathophysiology of irritable bowel syndrome. World J Gastroenterol 2020; 26(13): 1427-1438 [PMID: 32308344 DOI: 10.3748/wjg.v26.i13.1427] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Hod K, Ringel-Kulka T, Martin CF, Maharshak N, Ringel Y. High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome. J Clin Gastroenterol. 2016;50:227-232. [PMID: 25930973 DOI: 10.1097/mcg.0000000000000327] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
16 Khodabakhsh P, Khoie N, Dehpour AR, Abdollahi A, Ghazi-Khansari M, Shafaroodi H. Montelukast suppresses the development of irritable bowel syndrome phenotype possibly through modulating NF-κB signaling in an experimental model. Inflammopharmacology 2022. [PMID: 35013876 DOI: 10.1007/s10787-021-00907-7] [Reference Citation Analysis]
17 Zhang JJ, Ma H, Zhu JZ, Lu C, Yu CH, Li YM. The Role of Dietary Energy and Macronutrients Intake in Prevalence of Irritable Bowel Syndromes. Biomed Res Int 2019;2019:8967306. [PMID: 31223623 DOI: 10.1155/2019/8967306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
18 Vanuytsel T, Vanormelingen C, Vanheel H, Masaoka T, Salim Rasoel S, Tóth J, Houben E, Verbeke K, De Hertogh G, Vanden Berghe P, Tack J, Farré R. From intestinal permeability to dysmotility: the biobreeding rat as a model for functional gastrointestinal disorders. PLoS One 2014;9:e111132. [PMID: 25354336 DOI: 10.1371/journal.pone.0111132] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
19 Valentin N, Camilleri M, Carlson P, Harrington SC, Eckert D, O'Neill J, Burton D, Chen J, Shaw AL, Acosta A. Potential mechanisms of effects of serum-derived bovine immunoglobulin/protein isolate therapy in patients with diarrhea-predominant irritable bowel syndrome. Physiol Rep 2017;5:e13170. [PMID: 28275113 DOI: 10.14814/phy2.13170] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
20 Zhou TR, Huang JJ, Huang ZT, Cao HY, Tan B. Inhibitory effects of patchouli alcohol on stress-induced diarrhea-predominant irritable bowel syndrome. World J Gastroenterol 2018; 24(6): 693-705 [PMID: 29456408 DOI: 10.3748/wjg.v24.i6.693] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
21 Fragkos KC. Spotlight on eluxadoline for the treatment of patients with irritable bowel syndrome with diarrhea. Clin Exp Gastroenterol 2017;10:229-40. [PMID: 28989282 DOI: 10.2147/CEG.S123621] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
22 Bellini M, Berti G, Bonfrate L, Ciranni F, Di Ciaula A, Di Ruscio M, Dell'Era A, Lambiase C, Noto A, Pancetti A, Portincasa P, Rettura F. Use of GELSECTAN® in Patients with Irritable Bowel Syndrome (IBS): an Italian Experience. Patient Prefer Adherence 2021;15:1763-74. [PMID: 34413634 DOI: 10.2147/PPA.S318859] [Reference Citation Analysis]
23 Heitmann PT, Vollebregt PF, Knowles CH, Lunniss PJ, Dinning PG, Scott SM. Understanding the physiology of human defaecation and disorders of continence and evacuation. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34373626 DOI: 10.1038/s41575-021-00487-5] [Reference Citation Analysis]
24 Camilleri M, Shin A, Busciglio I, Carlson P, Acosta A, Bharucha AE, Burton D, Lamsam J, Lueke A, Donato LJ, Zinsmeister AR. Validating biomarkers of treatable mechanisms in irritable bowel syndrome. Neurogastroenterol Motil. 2014;26:1677-1685. [PMID: 25244349 DOI: 10.1111/nmo.12421] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
25 Henström M, Diekmann L, Bonfiglio F, Hadizadeh F, Kuech EM, von Köckritz-Blickwede M, Thingholm LB, Zheng T, Assadi G, Dierks C, Heine M, Philipp U, Distl O, Money ME, Belheouane M, Heinsen FA, Rafter J, Nardone G, Cuomo R, Usai-Satta P, Galeazzi F, Neri M, Walter S, Simrén M, Karling P, Ohlsson B, Schmidt PT, Lindberg G, Dlugosz A, Agreus L, Andreasson A, Mayer E, Baines JF, Engstrand L, Portincasa P, Bellini M, Stanghellini V, Barbara G, Chang L, Camilleri M, Franke A, Naim HY, D'Amato M. Functional variants in the sucrase-isomaltase gene associate with increased risk of irritable bowel syndrome. Gut 2018;67:263-70. [PMID: 27872184 DOI: 10.1136/gutjnl-2016-312456] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 10.8] [Reference Citation Analysis]
26 Bokic T, Storr M, Schicho R. Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An Overview. Pharmacology. 2015;96:76-85. [PMID: 26139425 DOI: 10.1159/000435816] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
27 Henström M, D'Amato M. Genetics of irritable bowel syndrome. Mol Cell Pediatr 2016;3:7. [PMID: 26873717 DOI: 10.1186/s40348-016-0038-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
28 Mayer EA, Savidge T, Shulman RJ. Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology. 2014;146:1500-1512. [PMID: 24583088 DOI: 10.1053/j.gastro.2014.02.037] [Cited by in Crossref: 234] [Cited by in F6Publishing: 192] [Article Influence: 29.3] [Reference Citation Analysis]
29 Lackner JM, Gudleski GD, Firth R, Keefer L, Brenner DM, Guy K, Simonetti C, Radziwon C, Quinton S, Krasner SS, Katz L, Garbarino G, Iacobucci GD, Sitrin MD. Negative aspects of close relationships are more strongly associated than supportive personal relationships with illness burden of irritable bowel syndrome. J Psychosom Res 2013;74:493-500. [PMID: 23731746 DOI: 10.1016/j.jpsychores.2013.03.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
30 El-Salhy M, Gilja OH, Gundersen D, Hatlebakk JG, Hausken T. Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (review). Int J Mol Med 2014;34:363-71. [PMID: 24939595 DOI: 10.3892/ijmm.2014.1811] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
31 Esmaillzadeh A, Keshteli AH, Hajishafiee M, Feizi A, Feinle-Bisset C, Adibi P. Consumption of spicy foods and the prevalence of irritable bowel syndrome. World J Gastroenterol 2013; 19(38): 6465-6471 [PMID: 24151366 DOI: 10.3748/wjg.v19.i38.6465] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
32 Vijayvargiya P, Camilleri M, Carlson P, Nair A, Nord SL, Ryks M, Rhoten D, Burton D, Busciglio I, Lueke A, Harmsen WS, Donato LJ. Effects of Colesevelam on Bowel Symptoms, Biomarkers, and Colonic Mucosal Gene Expression in Patients With Bile Acid Diarrhea in a Randomized Trial. Clin Gastroenterol Hepatol 2020;18:2962-2970.e6. [PMID: 32088296 DOI: 10.1016/j.cgh.2020.02.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
33 Jalanka J, Salonen A, Fuentes S, de Vos WM. Microbial signatures in post-infectious irritable bowel syndrome--toward patient stratification for improved diagnostics and treatment. Gut Microbes. 2015;6:364-369. [PMID: 26512631 DOI: 10.1080/19490976.2015.1096486] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 5.5] [Reference Citation Analysis]
34 Russell JP, Mohammadi E, Ligon CO, Johnson AC, Gershon MD, Rao M, Shen Y, Chan CC, Eidam HS, DeMartino MP, Cheung M, Oliff AI, Kumar S, Greenwood-Van Meerveld B. Exploring the Potential of RET Kinase Inhibition for Irritable Bowel Syndrome: A Preclinical Investigation in Rodent Models of Colonic Hypersensitivity. J Pharmacol Exp Ther 2019;368:299-307. [PMID: 30413627 DOI: 10.1124/jpet.118.252973] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
35 Min YW, Rhee PL. The clinical potential of ramosetron in the treatment of irritable bowel syndrome with diarrhea (IBS-D). Therap Adv Gastroenterol. 2015;8:136-142. [PMID: 25949526 DOI: 10.1177/1756283x15572580] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
36 Chira A, Braicu C, Budisan L, Ioan Chira R, Berindan-Neagoe I, Lucian Dumitrascu D. Monocyte chemotactic protein-1 and nitrotyrosine in irritable bowel syndrome. Exp Ther Med 2020;20:24-30. [PMID: 32508988 DOI: 10.3892/etm.2020.8665] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Del Chierico F, Vernocchi P, Dallapiccola B, Putignani L. Mediterranean diet and health: food effects on gut microbiota and disease control. Int J Mol Sci. 2014;15:11678-11699. [PMID: 24987952 DOI: 10.3390/ijms150711678] [Cited by in Crossref: 95] [Cited by in F6Publishing: 80] [Article Influence: 11.9] [Reference Citation Analysis]
38 Hujoel IA. Nutritional status in irritable bowel syndrome: A North American population-based study. JGH Open 2020;4:656-62. [PMID: 32782953 DOI: 10.1002/jgh3.12311] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Xu XJ, Liu L, Yao SK. Nerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target? J Zhejiang Univ Sci B. 2016;17:1-9. [PMID: 26739521 DOI: 10.1631/jzus.b1500181] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
40 Camilleri M. Review article: biomarkers and personalised therapy in functional lower gastrointestinal disorders. Aliment Pharmacol Ther. 2015;42:818-828. [PMID: 26264216 DOI: 10.1111/apt.13351] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.9] [Reference Citation Analysis]
41 Duboc H, Taché Y, Hofmann AF. The bile acid TGR5 membrane receptor: from basic research to clinical application. Dig Liver Dis 2014;46:302-12. [PMID: 24411485 DOI: 10.1016/j.dld.2013.10.021] [Cited by in Crossref: 229] [Cited by in F6Publishing: 216] [Article Influence: 28.6] [Reference Citation Analysis]
42 Quigley EM. Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye? Therap Adv Gastroenterol. 2016;9:199-212. [PMID: 26929782 DOI: 10.1177/1756283x15621230] [Cited by in Crossref: 42] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
43 Enck P, Aziz Q, Barbara G, Farmer AD, Fukudo S, Mayer EA, Niesler B, Quigley EM, Rajilić-Stojanović M, Schemann M, Schwille-Kiuntke J, Simren M, Zipfel S, Spiller RC. Irritable bowel syndrome. Nat Rev Dis Primers 2016;2:16014. [PMID: 27159638 DOI: 10.1038/nrdp.2016.14] [Cited by in Crossref: 338] [Cited by in F6Publishing: 292] [Article Influence: 56.3] [Reference Citation Analysis]
44 Mujagic Z, Tigchelaar EF, Zhernakova A, Ludwig T, Ramiro-Garcia J, Baranska A, Swertz MA, Masclee AA, Wijmenga C, van Schooten FJ, Smolinska A, Jonkers DM. A novel biomarker panel for irritable bowel syndrome and the application in the general population. Sci Rep. 2016;6:26420. [PMID: 27263852 DOI: 10.1038/srep26420] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
45 Volta U, Pinto-Sanchez MI, Boschetti E, Caio G, De Giorgio R, Verdu EF. Dietary Triggers in Irritable Bowel Syndrome: Is There a Role for Gluten? J Neurogastroenterol Motil. 2016;22:547-557. [PMID: 27426486 DOI: 10.5056/jnm16069] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
46 Wang XJ, Camilleri M. Personalized medicine in functional gastrointestinal disorders: Understanding pathogenesis to increase diagnostic and treatment efficacy. World J Gastroenterol 2019; 25(10): 1185-1196 [PMID: 30886502 DOI: 10.3748/wjg.v25.i10.1185] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
47 Undseth R, Jakobsdottir G, Nyman M, Berstad A, Valeur J. Low serum levels of short-chain fatty acids after lactulose ingestion may indicate impaired colonic fermentation in patients with irritable bowel syndrome. Clin Exp Gastroenterol 2015;8:303-8. [PMID: 26664152 DOI: 10.2147/CEG.S94084] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
48 Tang QL, Lin GY, Zhang MQ. Cognitive-behavioral therapy for the management of irritable bowel syndrome. World J Gastroenterol 2013; 19(46): 8605-8610 [PMID: 24379577 DOI: 10.3748/wjg.v19.i46.8605] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
49 Llanos-Chea A, Fasano A. Gluten and Functional Abdominal Pain Disorders in Children. Nutrients 2018;10:E1491. [PMID: 30322070 DOI: 10.3390/nu10101491] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
50 Zheng SC, Gong H, Wang YP, Zhang Q, Wang LL, Liao XF, He DW, Wu J. Health education program improves QOL in students with irritable bowel syndrome after the Wenchuan earthquake: a five-year multi-center study. BMC Gastroenterol 2018;18:119. [PMID: 30053840 DOI: 10.1186/s12876-018-0845-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Faresjö Å, Walter S, Norlin AK, Faresjö T, Jones MP. Gastrointestinal symptoms - an illness burden that affects daily work in patients with IBS. Health Qual Life Outcomes 2019;17:113. [PMID: 31262316 DOI: 10.1186/s12955-019-1174-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
52 Camilleri M, Carlson P, Chedid V, Vijayvargiya P, Burton D, Busciglio I. Aquaporin Expression in Colonic Mucosal Biopsies From Irritable Bowel Syndrome With Diarrhea. Clin Transl Gastroenterol 2019;10:e00019. [PMID: 31033595 DOI: 10.14309/ctg.0000000000000019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
53 El-Salhy M, Solomon T, Hausken T, Gilja OH, Hatlebakk JG. Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease. World J Gastroenterol 2017; 23(28): 5068-5085 [PMID: 28811704 DOI: 10.3748/wjg.v23.i28.5068] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
54 Hajiani E, Masjedizadeh A, Shayesteh AA, Babazadeh S, Seyedian SS. Comparison between gluten-free regime and regime with gluten in symptoms of patients with irritable bowel syndrome (IBS). J Family Med Prim Care 2019;8:1691-5. [PMID: 31198738 DOI: 10.4103/jfmpc.jfmpc_464_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
55 Camilleri M. Irritable Bowel Syndrome: Straightening the road from the Rome criteria. Neurogastroenterol Motil 2020;32:e13957. [PMID: 32808411 DOI: 10.1111/nmo.13957] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
56 Mittal R, Debs LH, Patel AP, Nguyen D, Patel K, O'Connor G, Grati M, Mittal J, Yan D, Eshraghi AA, Deo SK, Daunert S, Liu XZ. Neurotransmitters: The Critical Modulators Regulating Gut-Brain Axis. J Cell Physiol 2017;232:2359-72. [PMID: 27512962 DOI: 10.1002/jcp.25518] [Cited by in Crossref: 152] [Cited by in F6Publishing: 144] [Article Influence: 30.4] [Reference Citation Analysis]
57 Sumida K, Yamagata K, Kovesdy CP. Constipation in CKD. Kidney Int Rep 2020;5:121-34. [PMID: 32043026 DOI: 10.1016/j.ekir.2019.11.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
58 Jin DC, Cao HL, Xu MQ, Wang SN, Wang YM, Yan F, Wang BM. Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome. World J Gastroenterol 2016; 22(36): 8137-8148 [PMID: 27688655 DOI: 10.3748/wjg.v22.i36.8137] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 29] [Article Influence: 5.7] [Reference Citation Analysis]
59 Aoyama T, Fukumoto A, Shigita K, Asayama N, Mukai S, Nagata S. Bile pigment in small-bowel water content may reflect bowel habits: a retrospective analysis of a capsule endoscopy imaging series. BMC Gastroenterol 2020;20:237. [PMID: 32703159 DOI: 10.1186/s12876-020-01382-0] [Reference Citation Analysis]
60 Wu Y, Murray GK, Byrne EM, Sidorenko J, Visscher PM, Wray NR. GWAS of peptic ulcer disease implicates Helicobacter pylori infection, other gastrointestinal disorders and depression. Nat Commun 2021;12:1146. [PMID: 33608531 DOI: 10.1038/s41467-021-21280-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
61 Sofi F, Whittaker A, Gori AM, Cesari F, Surrenti E, Abbate R, Gensini GF, Benedettelli S, Casini A. Effect of Triticum turgidum subsp. turanicum wheat on irritable bowel syndrome: a double-blinded randomised dietary intervention trial. Br J Nutr 2014;111:1992-9. [PMID: 24521561 DOI: 10.1017/S000711451400018X] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 3.1] [Reference Citation Analysis]
62 Foxx-Orenstein AE. New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists. Therap Adv Gastroenterol 2016;9:354-75. [PMID: 27134665 DOI: 10.1177/1756283X16633050] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
63 Camilleri M. Sex as a biological variable in irritable bowel syndrome. Neurogastroenterol Motil 2020;32:e13802. [PMID: 31943595 DOI: 10.1111/nmo.13802] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
64 Petschow BW, Burnett BP, Shaw AL, Weaver EM, Klein GL. Dietary requirement for serum-derived bovine immunoglobulins in the clinical management of patients with enteropathy. Dig Dis Sci 2015;60:13-23. [PMID: 25142170 DOI: 10.1007/s10620-014-3322-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
65 Giamarellos-Bourboulis EJ, Pyleris E, Barbatzas C, Pistiki A, Pimentel M. Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage. BMC Gastroenterol. 2016;16:67. [PMID: 27402085 DOI: 10.1186/s12876-016-0484-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
66 Chedid V, Vijayvargiya P, Camilleri M. Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline. Clin Gastroenterol Hepatol 2018;16:336-8. [PMID: 29155353 DOI: 10.1016/j.cgh.2017.11.025] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
67 Söderquist F, Sundberg I, Ramklint M, Widerström R, Hellström PM, Cunningham JL. The Relationship Between Daytime Salivary Melatonin and Gastrointestinal Symptoms in Young Adults Seeking Psychiatric Care. Psychosom Med 2019;81:51-6. [PMID: 30299401 DOI: 10.1097/PSY.0000000000000644] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
68 Portincasa P, Bonfrate L, de Bari O, Lembo A, Ballou S. Irritable bowel syndrome and diet. Gastroenterol Rep (Oxf). 2017;5:11-19. [PMID: 28110300 DOI: 10.1093/gastro/gow047] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
69 Mehershahi S, Ghazanfar H, Ashraf S, Shaikh DH, Patel H. Colitis Induced by Colon-Cleansing Agent. Case Rep Gastroenterol 2021;15:621-5. [PMID: 34616266 DOI: 10.1159/000514440] [Reference Citation Analysis]
70 El-Salhy M, Gundersen D, Gilja OH, Hatlebakk JG, Hausken T. Is irritable bowel syndrome an organic disorder? World J Gastroenterol 2014; 20(2): 384-400 [PMID: 24574708 DOI: 10.3748/wjg.v20.i2.384] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 60] [Article Influence: 8.1] [Reference Citation Analysis]
71 Tarsitano F, Castelluzzo MA, Concolino D, Pensabene L. Functional Abdominal Pain. Curr Pediatr Rep 2018;6:67-78. [DOI: 10.1007/s40124-018-0158-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
72 Sandhu BK, Paul SP. Irritable bowel syndrome in children: Pathogenesis, diagnosis and evidence-based treatment. World J Gastroenterol 2014; 20(20): 6013-6023 [PMID: 24876724 DOI: 10.3748/wjg.v20.i20.6013] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
73 Acosta A, Camilleri M. Elobixibat and its potential role in chronic idiopathic constipation. Therap Adv Gastroenterol. 2014;7:167-175. [PMID: 25057297 DOI: 10.1177/1756283x14528269] [Cited by in Crossref: 47] [Cited by in F6Publishing: 15] [Article Influence: 5.9] [Reference Citation Analysis]
74 Mayer EA, Labus JS, Tillisch K, Cole SW, Baldi P. Towards a systems view of IBS. Nat Rev Gastroenterol Hepatol. 2015;12:592-605. [PMID: 26303675 DOI: 10.1038/nrgastro.2015.121] [Cited by in Crossref: 135] [Cited by in F6Publishing: 116] [Article Influence: 19.3] [Reference Citation Analysis]
75 Weerts ZZRM, Vork L, Mujagic Z, Keszthelyi D, Hesselink MAM, Kruimel J, Leue C, Muris JWM, Jonkers DMAE, Masclee AAM. Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome. Neurogastroenterol Motil 2019;31:e13629. [PMID: 31119844 DOI: 10.1111/nmo.13629] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
76 Shin A, Camilleri M, Vijayvargiya P, Busciglio I, Burton D, Ryks M, Rhoten D, Lueke A, Saenger A, Girtman A, Zinsmeister AR. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2013;11:1270-1275.e1. [PMID: 23639599 DOI: 10.1016/j.cgh.2013.04.020] [Cited by in Crossref: 88] [Cited by in F6Publishing: 90] [Article Influence: 9.8] [Reference Citation Analysis]
77 van Thiel IAM, de Jonge WJ, Chiu IM, van den Wijngaard RM. Microbiota-neuroimmune cross talk in stress-induced visceral hypersensitivity of the bowel. Am J Physiol Gastrointest Liver Physiol 2020;318:G1034-41. [PMID: 32308040 DOI: 10.1152/ajpgi.00196.2019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
78 Jarrett ME, Shulman RJ, Cain KC, Deechakawan W, Smith LT, Richebé P, Eugenio M, Heitkemper MM. Conditioned pain modulation in women with irritable bowel syndrome. Biol Res Nurs 2014;16:368-77. [PMID: 24463504 DOI: 10.1177/1099800413520486] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
79 Camilleri M. Advances in understanding of bile acid diarrhea. Expert Rev Gastroenterol Hepatol. 2014;8:49-61. [PMID: 24410472 DOI: 10.1586/17474124.2014.851599] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 6.0] [Reference Citation Analysis]
80 Waldman SA, Tenenbaum R, Foehl HC, Winkle P, Griffin P. Blunted Evoked Prouroguanylin Endocrine Secretion in Chronic Constipation. Clin Transl Gastroenterol 2019;10:e00016. [PMID: 31318728 DOI: 10.14309/ctg.0000000000000016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
81 Kennedy PJ, Cryan JF, Dinan TG, Clarke G. Irritable bowel syndrome: A microbiome-gut-brain axis disorder? World J Gastroenterol 2014; 20(39): 14105-14125 [PMID: 25339800 DOI: 10.3748/wjg.v20.i39.14105] [Cited by in CrossRef: 178] [Cited by in F6Publishing: 146] [Article Influence: 22.3] [Reference Citation Analysis]
82 Tsang SW, Auyeung KK, Bian ZX, Ko JK. Pathogenesis, Experimental Models and Contemporary Pharmacotherapy of Irritable Bowel Syndrome: Story About the Brain-Gut Axis. Curr Neuropharmacol. 2016;14:842-856. [PMID: 27009115 DOI: 10.2174/1570159x14666160324144154] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
83 Shin A, Preidis GA, Shulman R, Kashyap PC. The Gut Microbiome in Adult and Pediatric Functional Gastrointestinal Disorders. Clin Gastroenterol Hepatol 2019;17:256-74. [PMID: 30153517 DOI: 10.1016/j.cgh.2018.08.054] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 11.8] [Reference Citation Analysis]
84 Tziatzios G, Gkolfakis P, Papanikolaou IS, Mathur R, Pimentel M, Giamarellos-Bourboulis EJ, Triantafyllou K. Gut Microbiota Dysbiosis in Functional Dyspepsia. Microorganisms 2020;8:E691. [PMID: 32397332 DOI: 10.3390/microorganisms8050691] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
85 El-Salhy M. Recent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol 2015; 21(25): 7621-7636 [PMID: 26167065 DOI: 10.3748/wjg.v21.i25.7621] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 52] [Article Influence: 8.0] [Reference Citation Analysis]
86 Klein GL, Petschow BW, Shaw AL, Weaver E. Gut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target. Curr Opin Support Palliat Care 2013;7:361-7. [PMID: 24157715 DOI: 10.1097/SPC.0000000000000017] [Cited by in Crossref: 49] [Cited by in F6Publishing: 21] [Article Influence: 6.1] [Reference Citation Analysis]
87 Jiang D, Huang D, Cai W, Li T, Wang Y, Chen H, Guan T, Ma X. G protein beta 3(GNβ3) C825T polymorphism and irritable bowel syndrome susceptibility: an updated meta-analysis based on eleven case-control studies. Oncotarget 2018;9:2770-81. [PMID: 29416810 DOI: 10.18632/oncotarget.23449] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
88 Camilleri M, Klee EW, Shin A, Carlson P, Li Y, Grover M, Zinsmeister AR. Irritable bowel syndrome-diarrhea: characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit. Am J Physiol Gastrointest Liver Physiol 2014;306:G13-26. [PMID: 24200957 DOI: 10.1152/ajpgi.00294.2013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
89 Harvie RM, Chisholm AW, Bisanz JE, Burton JP, Herbison P, Schultz K, Schultz M. Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs. World J Gastroenterol 2017; 23(25): 4632-4643 [PMID: 28740352 DOI: 10.3748/wjg.v23.i25.4632] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 53] [Article Influence: 12.6] [Reference Citation Analysis]
90 Camilleri M, Carlson P, Acosta A, Busciglio I, Nair AA, Gibbons SJ, Farrugia G, Klee EW. RNA sequencing shows transcriptomic changes in rectosigmoid mucosa in patients with irritable bowel syndrome-diarrhea: a pilot case-control study. Am J Physiol Gastrointest Liver Physiol. 2014;306:G1089-G1098. [PMID: 24763552 DOI: 10.1152/ajpgi.00068.2014] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
91 Capasso R, Orlando P, Pagano E, Aveta T, Buono L, Borrelli F, Di Marzo V, Izzo AA. Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1 channels. Br J Pharmacol. 2014;171:4026-4037. [PMID: 24818658 DOI: 10.1111/bph.12759] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 7.7] [Reference Citation Analysis]
92 Ringel-Kulka T, Choi CH, Temas D, Kim A, Maier DM, Scott K, Galanko JA, Ringel Y. Altered Colonic Bacterial Fermentation as a Potential Pathophysiological Factor in Irritable Bowel Syndrome. Am J Gastroenterol. 2015;110:1339-1346. [PMID: 26303129 DOI: 10.1038/ajg.2015.220] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 9.0] [Reference Citation Analysis]
93 Vella A, Camilleri M. The Gastrointestinal Tract as an Integrator of Mechanical and Hormonal Response to Nutrient Ingestion. Diabetes 2017;66:2729-37. [PMID: 29061658 DOI: 10.2337/dbi17-0021] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
94 Hu Y, Chen F, Ye H, Lu B. Integrative analysis of the gut microbiome and metabolome in a rat model with stress induced irritable bowel syndrome. Sci Rep 2021;11:17596. [PMID: 34475489 DOI: 10.1038/s41598-021-97083-z] [Reference Citation Analysis]
95 El-Salhy M, Umezawa K, Hatlebakk JG, Gilja OH. Abnormal differentiation of stem cells into enteroendocrine cells in rats with DSS-induced colitis. Mol Med Rep. 2017;15:2106-2112. [PMID: 28259987 DOI: 10.3892/mmr.2017.6266] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
96 Schenck Eidam H, Russell J, Raha K, DeMartino M, Qin D, Guan HA, Zhang Z, Zhen G, Yu H, Wu C, Pan Y, Joberty G, Zinn N, Laquerre S, Robinson S, White A, Giddings A, Mohammadi E, Greenwood-Van Meerveld B, Oliff A, Kumar S, Cheung M. Discovery of a First-in-Class Gut-Restricted RET Kinase Inhibitor as a Clinical Candidate for the Treatment of IBS. ACS Med Chem Lett 2018;9:623-8. [PMID: 30034590 DOI: 10.1021/acsmedchemlett.8b00035] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
97 Wilson D, Evans M, Weaver E, Shaw AL, Klein GL. Evaluation of serum-derived bovine immunoglobulin protein isolate in subjects with diarrhea-predominant irritable bowel syndrome. Clin Med Insights Gastroenterol 2013;6:49-60. [PMID: 24833942 DOI: 10.4137/CGast.S13200] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
98 Bhesania N, Cresci GAM. A nutritional approach for managing irritable bowel syndrome. Curr Opin Pediatr 2017;29:584-91. [PMID: 28737582 DOI: 10.1097/MOP.0000000000000536] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
99 Camilleri M. Physiological underpinnings of irritable bowel syndrome: neurohormonal mechanisms. J Physiol. 2014;592:2967-2980. [PMID: 24665101 DOI: 10.1113/jphysiol.2014.270892] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 7.3] [Reference Citation Analysis]
100 Petschow BW, Blikslager AT, Weaver EM, Campbell JM, Polo J, Shaw AL, Burnett BP, Klein GL, Rhoads JM. Bovine immunoglobulin protein isolates for the nutritional management of enteropathy. World J Gastroenterol 2014; 20(33): 11713-11726 [PMID: 25206275 DOI: 10.3748/wjg.v20.i33.11713] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
101 Camilleri M, Carlson P, Valentin N, Acosta A, O'Neill J, Eckert D, Dyer R, Na J, Klee EW, Murray JA. Pilot study of small bowel mucosal gene expression in patients with irritable bowel syndrome with diarrhea. Am J Physiol Gastrointest Liver Physiol. 2016;311:G365-G376. [PMID: 27445342 DOI: 10.1152/ajpgi.00037.2016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
102 El-Salhy M, Mazzawi T, Hausken T, Hatlebakk JG. Interaction between diet and gastrointestinal endocrine cells. Biomed Rep. 2016;4:651-656. [PMID: 27284402 DOI: 10.3892/br.2016.649] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
103 Liang CM, Hsu CH, Chung CH, Chen CY, Wang LY, Hsu SD, Chang PK, Hong ZJ, Chien WC, Hu JM. Risk for Irritable Bowel Syndrome in Patients with Helicobacter Pylori Infection: A Nationwide Population-Based Study Cohort Study in Taiwan. Int J Environ Res Public Health 2020;17:E3737. [PMID: 32466223 DOI: 10.3390/ijerph17103737] [Reference Citation Analysis]
104 O'Malley D. Neuroimmune Cross Talk in the Gut. Neuroendocrine and neuroimmune pathways contribute to the pathophysiology of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2016;311:G934-41. [PMID: 27742703 DOI: 10.1152/ajpgi.00272.2016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
105 El-Salhy M, Hatlebakk JG, Hausken T. Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones. Nutrients. 2019;11. [PMID: 31394793 DOI: 10.3390/nu11081824] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]